Related Experiment Videos
Protein-losing enteropathy in systemic lupus erythematosus
S E Edmunds1, V Ganju, B R Beveridge
1Department of General Medicine, Sir Charles Gairdner Hospital, Nedlands, W.A.
Australian and New Zealand Journal of Medicine
|December 1, 1988
Summary
Two patients with systemic lupus erythematosus (SLE) experienced severe protein loss due to enteropathy. Anti-(U1)RNP antibodies may indicate this rare SLE complication, which responded well to prednisolone treatment.
Area of Science:
- Rheumatology and Gastroenterology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse clinical manifestations.
- Protein-losing enteropathy (PLE) is a rare but serious gastrointestinal complication of SLE.
Observation:
- Two SLE patients presented with anasarca, pleural effusions, and severe hypoalbuminemia.
- Gastrointestinal protein loss was confirmed, with other causes excluded.
- Both patients exhibited circulating antinuclear factor (ANF) with speckled staining, anti-(U1)RNP antibodies, and low serum complement levels.
Findings:
- The study identified a potential link between anti-(U1)RNP antibodies and PLE in SLE.
- Complete remission was achieved in both patients following treatment with prednisolone.
- These findings suggest a specific subset of SLE characterized by prominent PLE.
Implications:
- Anti-(U1)RNP antibodies could serve as a biomarker for identifying SLE patients at risk of developing PLE.
- Early recognition and treatment of PLE in SLE may improve patient outcomes.
- Further research into the pathogenesis of PLE in SLE is warranted.